               SEQUENCE LISTING

<110> REGULAXIS
      CARELLI Claude
      VTU Christelle
      PAOLINI Raffaello	

<120> PEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS

<130> CV - 634/PCT

<160> 20

<170> BiSSAP 1.3.6

<210> 1
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> X is vacant or is V or is RV or is DRV or is SDV or is DSDV or is
      any of SEQ ID NO: 5-7

<220> 
<223> Chimeric peptide

<220> 
<221> SITE
<222> 3
<223> X is either of EK, ES or DL

<220> 
<221> SITE
<222> 5
<223> X is vacant or is K or is KD or is KDL or is any of SEQ ID NO:
      8-14

<220> 
<221> SITE
<222> 8
<223> X is either of C, S, Y, F, D, E, A or G

<220> 
<221> SITE
<222> 13
<223> X is vacant or is W or is WK or is WKT or is any of SEQ ID NO:
      15-19

<400> 1
Xaa Tyr Xaa Leu Xaa Ala Gly Xaa Lys Asn Phe Phe Xaa 
1               5                   10              

<210> 2
<211> 25
<212> PRT
<213> Artificial Sequence


<220> 
<223> Chimeric peptide

<400> 2
Gly Ala Ser Asp Ser Asp Val Tyr Asp Leu Leu Ala Gly Ser Lys Asn 
1               5                   10                  15      
Phe Phe Trp Lys Thr Phe Thr Ser Ser 
            20                  25  

<210> 3
<211> 26
<212> PRT
<213> Artificial Sequence


<220> 
<223> Chimeric peptide

<400> 3
Gly Ala Ser Asp Ser Asp Val Tyr Asp Leu Leu Lys Ala Gly Ser Lys 
1               5                   10                  15      
Asn Phe Phe Trp Lys Thr Phe Thr Ser Ser 
            20                  25      

<210> 4
<211> 24
<212> PRT
<213> Artificial Sequence


<220> 
<223> Chimeric peptide

<400> 4
Gly Thr Ser Asp Arg Val Tyr Glu Lys Leu Ala Gly Ser Lys Asn Phe 
1               5                   10                  15      
Phe Trp Lys Thr Phe Thr Ser Ser 
            20                  

<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 1 of chimeric peptide

<220> 
<221> SITE
<222> 3
<223> X is either of R or SD or SN

<400> 5
Ser Asp Xaa Val 
1               

<210> 6
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> X is R (when X in position 4 is T) or is SD or SN (when X in
      position 4 is A)

<220> 
<223> Position 1 of chimeric peptide

<220> 
<221> SITE
<222> 4
<223> X is T (when X in position 1 is R) or is A (when X in position 1
      is SD or SN)

<400> 6
Xaa Ser Asp Xaa Val 
1               5   

<210> 7
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 1 of chimeric peptide

<220> 
<221> SITE
<222> 2
<223> X is R (when X in position 5 is T) or is SD or SN (when X in
      position 5 is A)

<220> 
<221> SITE
<222> 5
<223> X is T (when X in position 2 is R) or is A (when X in position 2
      is SD or SN)

<400> 7
Gly Xaa Ser Asp Xaa Val 
1               5       

<210> 8
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<400> 8
Lys Asp Leu Glu 
1               

<210> 9
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<400> 9
Lys Asp Leu Glu Glu 
1               5   

<210> 10
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<400> 10
Lys Asp Leu Glu Glu Gly 
1               5       

<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<400> 11
Lys Asp Leu Glu Glu Gly Ile 
1               5           

<210> 12
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<400> 12
Lys Asp Leu Glu Glu Gly Ile Gln 
1               5               

<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<220> 
<221> SITE
<222> 9
<223> X is A or T

<400> 13
Lys Asp Leu Glu Glu Gly Ile Gln Xaa 
1               5                   

<210> 14
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 5 of chimeric peptide

<220> 
<221> SITE
<222> 9
<223> X is A or T

<400> 14
Lys Asp Leu Glu Glu Gly Ile Gln Xaa Leu 
1               5                   10  

<210> 15
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 13 of chimeric peptide

<400> 15
Trp Lys Thr Phe 
1               

<210> 16
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 13 of chimeric peptide

<400> 16
Trp Lys Thr Phe Thr 
1               5   

<210> 17
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 13 of chimeric peptide

<400> 17
Trp Lys Thr Phe Thr Ser 
1               5       

<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 13 of chimeric peptide

<220> 
<221> SITE
<222> 7
<223> X is either of C, S, Y, F, D, E, A or G

<400> 18
Trp Lys Thr Phe Thr Ser Xaa 
1               5           

<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Position 13 of chimeric peptide

<220> 
<221> SITE
<222> 7
<223> X is either of C, S, Y, F, D, E, A or G

<400> 19
Trp Lys Thr Phe Thr Ser Xaa Lys Gln Ala 
1               5                   10  

<210> 20
<211> 26
<212> PRT
<213> Artificial Sequence


<220> 
<223> Chimeric peptide

<400> 20
Gly Ala Ser Asp Ser Asn Val Tyr Asp Leu Leu Lys Ala Gly Ser Lys 
1               5                   10                  15      
Asn Phe Phe Trp Lys Thr Phe Thr Ser Ser 
            20                  25      

